TD Cowen boosted Puma Biotechnology's price target while insider trading disclosures were filed under Rule 10b5-1.
2 reports, 2 independent
Updated Aug 18
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen boosted Puma Biotechnology's price target while insider trading disclosures were filed under Rule 10b5-1.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Analyst firms dropped price objectives and insider trading disclosures were filed with the SEC.
- Multiple financial firms, including Keefe, Bruyette & Woods, Jefferies, and TD Cowen, adjusted price targets and ratings on September 24, 2026.
- TD Cowen raised its price target on Exelixis shares on August 30, 2026.
- TD Cowen lifted its price objective on shares of Iovance Biotherapeutics.
- Restaurant Brands received a price objective and disclosed an insider sale via SEC filing.